Literature DB >> 7512677

Anatomic subtype and survival after reconstructive operation for hypoplastic left heart syndrome.

R A Jonas1, D D Hansen, N Cook, D Wessel.   

Abstract

We conducted a retrospective study of 78 patients who underwent palliative reconstructive operation for hypoplastic left heart syndrome representing an entire consecutive experience between 1983 and 1991 to identify predictors of mortality that might enable more appropriate triage of patients to either reconstruction or transplantation. Twenty-nine patients had aortic atresia, mitral atresia; 18 had aortic stenosis, mitral stenosis; 20 had aortic atresia and mitral stenosis; and 11 had miscellaneous forms of hypoplastic left heart syndrome. There were 29 hospital deaths (37%). A worst preoperative pH (p = 0.01) and immediate preoperative pH (p = 0.03) less than the median were predictors of hospital mortality. The anatomic subgroup aortic atresia, mitral stenosis (p = 0.06) had a possible increased hospital mortality. One patient was lost to follow-up. The Kaplan-Meier survival estimate among hospital survivors was 34% at 3 years and 25% at 5 years. The anatomic subgroup aortic atresia, mitral atresia (p = 0.02) had a worse late outcome (11% 3-year survival) whereas the subgroup aortic stenosis, mitral stenosis (p = 0.04; 76% 3-year survival) had a better late outcome. There were no other significant predictors of late survival other than immediate prerepair pH (p = 0.05). Interpretation of this experience is complicated by the large number of different surgical techniques used for both first-stage neonatal reconstruction and the Fontan procedure plus introduction of the bidirectional Glenn shunt as an intermediate step midway through the experience. Nevertheless in this time frame and with the variety of techniques used, this experience demonstrates that patients with aortic atresia, mitral atresia, particularly those who have been very acidotic in the neonatal period, are least likely to do well with the reconstructive approach to hypoplastic left heart syndrome and are the most appropriate subgroup to be directed to transplantation. Patients with aortic stenosis, mitral stenosis have an excellent late outcome with the reconstructive approach.

Entities:  

Mesh:

Year:  1994        PMID: 7512677

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  16 in total

1.  [Norwood procedure to hypoplastic left heart syndrome].

Authors:  S Sano; M Kawada; H Yoshida; K Kino; H Irie; A Aoki; H Mitani; K Nakamura; M Inoue
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-12

2.  A risk assessment scoring system predicts survival following the Norwood procedure.

Authors:  P A Checchia; J K McGuire; S Morrow; N Daher; C Huddleston; F Levy
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

3.  Risk-stratified approach to hybrid transcatheter-surgical palliation of hypoplastic left heart syndrome.

Authors:  D S Lim; B B Peeler; G P Matherne; I L Kron; H P Gutgesell
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

4.  Hypoplastic left heart syndrome and aortic atresia-mitral stenosis variant: role of myocardial protection strategy and impact of ventriculo-coronary connections after stage I palliation.

Authors:  Anastasios C Polimenakos; Shyam K Sathanandam; Tarek S Husayni; Chawki F El Zein; David A Roberson; Michel N Ilbawi
Journal:  Pediatr Cardiol       Date:  2011-06-05       Impact factor: 1.655

5.  Staged surgical management of hypoplastic left heart syndrome: a single institution 12 year experience.

Authors:  S P McGuirk; M Griselli; O F Stumper; E M Rumball; P Miller; R Dhillon; J V de Giovanni; J G Wright; D J Barron; W J Brawn
Journal:  Heart       Date:  2005-06-06       Impact factor: 5.994

Review 6.  Hypoplastic left heart syndrome: current considerations and expectations.

Authors:  Jeffrey A Feinstein; D Woodrow Benson; Anne M Dubin; Meryl S Cohen; Dawn M Maxey; William T Mahle; Elfriede Pahl; Juan Villafañe; Ami B Bhatt; Lynn F Peng; Beth Ann Johnson; Alison L Marsden; Curt J Daniels; Nancy A Rudd; Christopher A Caldarone; Kathleen A Mussatto; David L Morales; D Dunbar Ivy; J William Gaynor; James S Tweddell; Barbara J Deal; Anke K Furck; Geoffrey L Rosenthal; Richard G Ohye; Nancy S Ghanayem; John P Cheatham; Wayne Tworetzky; Gerard R Martin
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

7.  The Impact of the Left Ventricle on Right Ventricular Function and Clinical Outcomes in Infants with Single-Right Ventricle Anomalies up to 14 Months of Age.

Authors:  Meryl S Cohen; Nicholas Dagincourt; Victor Zak; Jeanne Marie Baffa; Peter Bartz; Andreea Dragulescu; Gul Dudlani; Heather Henderson; Catherine D Krawczeski; Wyman W Lai; Jami C Levine; Alan B Lewis; Rachel T McCandless; Richard G Ohye; Sonal T Owens; Steven M Schwartz; Timothy C Slesnick; Carolyn L Taylor; Peter C Frommelt
Journal:  J Am Soc Echocardiogr       Date:  2018-07-03       Impact factor: 5.251

8.  Prolonged PR Interval at Birth Predicting the High Occurrence of Fatal Atrioventricular Block in Hypoplastic Left Heart Syndrome.

Authors:  Eiji Morihana; Kenichiro Yamamura; Yuichiro Sugitani; Hideaki Kado; Yasushi Takahata; Toshihide Nakano; Yasutaka Nakashima; Naoki Fusazaki; Shouichi Ohga
Journal:  Pediatr Cardiol       Date:  2018-01-19       Impact factor: 1.655

9.  Identified mortality risk factors associated with presentation, initial hospitalisation, and interstage period for the Norwood operation in a multi-centre registry: a report from the national pediatric cardiology-quality improvement collaborative.

Authors:  Russell R Cross; Ashraf S Harahsheh; Robert McCarter; Gerard R Martin
Journal:  Cardiol Young       Date:  2013-02-06       Impact factor: 1.093

10.  Coronary Arteries in Childhood Heart Disease: Implications for Management of Young Adults.

Authors:  Fernando Baraona; Anne Marie Valente; Prashob Porayette; Francesca Romana Pluchinotta; Stephen P Sanders
Journal:  J Clin Exp Cardiolog       Date:  2012-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.